In addition, HIPK2 is transcriptionally regulated by nuclear factor erythroid 2 and HIPK2 knockdown increased the sensitivity to cisplatin in non-small cell lung cancer (NSCLC) cells [14]. Here, HIPK2 is linked to non-small cell lung carcinoma.